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Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated
host response to infection; no current clinical measure adequately reflects the
concept of dysregulated response. Coagulation plays a pivotal role in the normal
response to pathogens (immunothrombosis), thus the evolution toward sepsis-induced
coagulopathy could be individuate through coagulation/fibrinolysis-related biomarkers.
We focused on the role of D-dimer assessed within 24 h after admission in predicting
clinical outcomes in a cohort of 270 patients hospitalized in a 79 months period
for meningitis and/or bloodstream infections due to Streptococcus pneumoniae (n
= 162) or Neisseria meningitidis (n = 108). Comparisons were performed with
unpaired t-test, Mann-Whitney-test or chi-squared-test with continuity correction,
as appropriate, and multivariable logistic regression analysis was performed with
Bayesian model averaging. In-hospital mortality was 14.8% for the overall population,
significantly higher in S. pneumoniae than in N. meningitidis patients: 19.1 vs.
8.3%, respectively (p = 0.014). At univariable logistic regression analysis the
following variables were significantly associated with in-hospital mortality: pneumococcal
etiology, female sex, age, ICU admission, SOFA score, septic shock, MODS,
and D-dimer levels. At multivariable analysis D-dimer showed an effect only in
N. meningitidis subgroup: as 500 ng/mL of D-dimer increased, the probability
of unfavorable outcome increased on average by 4%. Median D-dimer was
significantly higher in N. meningitidis than in S. pneumoniae patients (1,314 vs.
1,055 ng/mL, p = 0.009). For N. meningitidis in-hospital mortality was 0% for D-dimer
<500 ng/mL, very low (3.5%) for D-dimer <7,000 ng/mL, and increased to 26.1% for
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D-dimer >7,000 ng/mL. Kaplan-Meier analysis of in-hospital mortality showed for N.
meningitidis infections a statistically significant difference for D-dimer >7,000 ng/mL
compared to values <500 ng/mL (p = 0.021) and 500–3,000 ng/mL (p = 0.002).
For S. pneumoniae the mortality risk resulted always high, over 10%, irrespective by
D-dimer values. In conclusion, D-dimer is rapid to be obtained, at low cost and available
everywhere, and can help stratify the risk of in-hospital mortality and complications in
patients with invasive infections due to N. meningitidis: D-dimer <500 ng/mL excludes
any further complications, and a cut-off of 7,000 ng/mL seems able to predict a
significantly increased mortality risk from much <10% to over 25%.
Keywords: D-dimer, biomarker, sepsis, meningitis, Streptococcus pneumoniae, Neisseria meningitidis, mortality
INTRODUCTION
Sepsis is a heterogeneous syndrome defined as a life-threatening
organ dysfunction caused by a dysregulated host response to
infection, associated with an in-hospital mortality >10% (1, 2).
The role of biomarkers [biological observations that substitute
for and ideally predict a clinically relevant endpoint (3)] for
diagnostic and prognostic assessment in case of sepsis has been
extensively investigated in literature, but to date no current
clinical measure seems able to reflect the concept of “dysregulated
host response” (1); therefore, identifying a biomarker reflective of
host-response interaction would be of great interest.
It has been known for several years that coagulation plays
a pivotal role in the physiological host response to pathogens:
immunothrombosis, mediated by immune cells and by specific
thrombosis-related molecules, leads to the generation of a
localized intravascular scaffold that facilitates the recognition,
containment and killing of pathogens, limiting their diffusion
through the circulatory system, thus protecting host integrity and
limiting major organ damage (4): the loss of the physiologically
localized activation of coagulation, the signature feature of
disseminated intravascular coagulation (DIC), is a hallmark of
sepsis and invasive infections (4). In general, during a systemic
infection, both extrinsic and contact coagulation pathways
are activated, the first mainly triggered by the intravascular
tissue factor (TF) expressed on the monocytes and extracellular
microparticles (MPs) surfaces, the second by the cell-free
DNA associated with neutrophil extracellular traps (NETs)
and by the phosphatidylserine residues present in various cell
membranes (4). Sepsis-associated coagulopathy is characterized
by concomitant activation of coagulation, down-regulation of
physiological anticoagulants, and inhibition of fibrinolysis (5),
finally leading to the generation of a variable amount of fibrin-
related markers, such as the D-dimer.
Several biomarkers indicating a strong fibrinolytic shutdown,
including low D-dimer levels, were found to be associated with
a reduced survival in patients with sepsis (6); recently a very
high mortality among the few sepsis patients having normal D-
dimer levels (<500 ng/mL) was once again reported (7). On the
contrary, other studies showed that the mortality is effectively
predicted by high levels, with D-dimer ≥4,200 ng/mL effective
in identifying the patients with infective endocarditis (IE) (8)
and ≥4,000 ng/mL for those with bloodstream infections (BSI)
(9); moreover, a linear relationship between high D-dimer levels
and mortality in sepsis patients admitted to the emergency
department has been reported (10). On-admission D-dimer
levels ≥2,000 ng/mL were able to effectively predict in-hospital
mortality also among Covid-19 patients (11).
D-dimer seems to be therefore an interesting biomarker
in predicting prognosis in different models of infection, able
to reflect the synthesis of the complex balance between the
pro- and anti-thrombotic and the pro- and anti-fibrinolytic
drive occurring during sepsis-related coagulopathy. However,
the dysregulated host response occurring during an invasive
infection depends on the specific pathogen involved (4, 12); it is
plausible to hypothesize that the levels of a coagulative biomarker,
and the related thresholds, should be assessed and differently
interpreted for each pathogen. Infections due to Streptococcus
pneumoniae and Neisseria meningitidis represent two excellent
models of severe invasive infections due, respectively, to
Gram-positive and Gram-negative cocci whose pathogenesis
is usually characterized by an extensive coagulopathy and
sometimes overt-DIC.
The aim of this study is to evaluate in a large cohort of
patients with meningitis and/or BSI due to S. pneumoniae or N.
meningitidis the main clinical and laboratory characteristics
and variables associated with in-hospital mortality and
complications, with a particular focus on the role of D-dimer as
biomarker for early prediction of clinically relevant outcomes.
MATERIALS AND METHODS
Study Design, Setting, and Subjects
A retrospective study was conducted from November 2012
to May 2019 (79 months), enrolling all consecutive patients
admitted for meningitis and/or BSI due to S. pneumoniae or N.
meningitidis to the First Division of Infectious Diseases (FDID)
of Cotugno Hospital, in Naples, Italy, a referral tertiary hospital
covering an area (Campania region) with 5,800,000 inhabitants.
This division has 25 beds dedicated to the management of
invasive bacterial infections and other infectious diseases.
All patients enrolled in this study underwent blood cultures
and, if not contraindicated, lumbar puncture.
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In each patient, a complete blood analysis, including
assessment of D-dimer, was performed within the first 24 h after
admission. Patients for which the main laboratory and clinical
data and primary clinical outcome were available were enrolled
for the final analysis. No exclusion criteria were applied regarding
the age of patients and the severity of clinical condition.
We assessed in each patient the presence of purpura with onset
within 24 h after admission.
In each patient, within the first 24 h after admission, the ISTH
overt-DIC score (13, 14), the SIC score (15), the Sequential Organ
Failure Assessment (SOFA) score, were calculated according to
current definitions, and multiple organ dysfunction syndrome
(MODS) and septic shock (1) status was assessed.
Data Collection
The computerized database of the FDID was searched to identify
all consecutive inpatients with meningitis and/or BSI due to S.
pneumoniae or N. meningitidis, diagnosed between November
2012 and May 2019.
Data were obtained by electronic clinical chart review and
interrogation of laboratory information systems and collected in
a dedicated case record form.
Clinical information, including demographics, antimicrobial
therapy, and laboratory data were retrieved from medical charts.
Clinical outcomes were retrieved from the electronic clinical
chart related to the index hospitalization.
This study was exempt from institutional review board
oversight because of its retrospective nature and the anonymity
of pooled data.
Definitions
Sepsis and septic shock were defined according to the sepsis-3
definition (1).
Multiple organ dysfunction syndrome (MODS) was defined
as the presence of altered function involving at least two organ
systems in an acutely ill patient such that homeostasis cannot be
maintained without intervention.
Purpura was defined as petechial rash rapidly spreading in
extent and depth, evolving into skin necrosis.
Antibiotic therapy was defined as adequate if the isolated
pathogen resulted susceptible to the tested antibiotic according to
EUCAST clinical breakpoints effective during the study period.
Clinical Outcomes
The primary outcome was in-hospital mortality.
The secondary outcome was a composite of in-hospital
mortality, amputations, hearing loss, neurological complications
(stroke, transitory ischemic attack, brain abscess, epilepsy).
Coagulation Testing
Prothrombin time/INR, fibrinogen and D-dimer were measured
using the ACL TOP analyzer (Instrumentation Laboratory-IL,
Werfen Group).
Q.F.A. Thrombin (Bovine) kit was used for the quantitative
determination of fibrinogen, based on the Clauss method, in
human citrated plasma on the IL Coagulation Systems.
The quantitative determination of D-dimer in human citrated
plasma was determined by the automated latex enhanced
immunoassay HemosIL D-Dimer HS (0020007700).
D-dimer classes were divided as follows: <500, 500–3,000,
3,000–7,000, and >7,000 ng/mL. The cut-off values of 3,000 and
7,000 ng/mL were chosen according to the proposal of ISTH
about the proper values for moderate (2 points) and severe (3
points) increase in the ISTH overt-DIC score (14).
Microbiology Laboratory Methods
Blood cultures were inoculated in BD BACTECTM blood
culture bottles (Becton, Dickinson and Company, NJ, U.S.) and
monitored using BD BACTECTM FX instrument for up to 5
days. Positive cultures were sub-cultured and identified to the
species level by Vitek R©MS or Vitek R©2 (BioMérieux; Marcy-
l’Étoile, France).
Cerebrospinal fluid (CSF) was first examined by a Gram-
stained smear, and the appropriate culture media was inoculated.
Blood agar and chocolate agar plates should be incubated at
35◦C in an atmosphere enriched with carbon dioxide. CSF was
cultured and identified to the species level by Vitek R©MS or
Vitek R©2 (BioMérieux; Marcy-l’Étoile, France).
Susceptibility testing was performed using Vitek R©2 system
and interpreted according to EUCAST criteria effective during
the study period.
Polymerase chain reaction (PCR) for the detection of
meningococcal and pneumococcal DNA on blood specimens,
antigen detection on CSF and Biofire R© FilmArrayTM
meningitis/encephalitis (ME) panel (a multiplex PCR assay
which can detect the most commonly identified pathogens
in central nervous system infections) were performed when
adequate and/or available during the study period.
Statistical Analysis
Descriptive analysis of the data was carried out usingmean values
and standard deviation (SD) or median values and interquartile
range (IQR) for the quantitative variables, as appropriate, and
percentage values for the qualitative ones. Normality of the
variables was assessed with the Shapiro-Wilk-test. Comparisons
between groups were performed with unpaired two-tailed t-
test, Mann-Whitney-test or chi-squared-test with continuity
correction, as appropriate.
The data related to in-hospital mortality was analyzed with
Kaplan-Meier curves.
The association with the outcome of each considered
predictor was investigated with univariable logistic regression.
Predictors with a p-value <0.20 at the univariable logistic
regression were considered for multivariable analysis.
The variable “Interaction” is “D-dimer-N. meningitidis,” and
represents the D-dimer in this specific subgroup; this explicitly
entered the analysis because it expresses the main hypothesis
of the work. For the D-dimer odds ratio (OR), an increase of
500 ng/mL was considered.
Multivariable logistic regression analysis was performed
with Bayesian model averaging (BMA) (16) to address model
uncertainty, producing a posterior probability for each possible
model and predictor. As a result of multivariable analysis, in
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addition to OR, the probability that the single variable has a non-
zero effect in the final multivariable model [posterior probability,
p (b 6= 0)] was reported. The variables with p (b 6= 0) > 0.80
were selected.
A p-value of <0.05 was considered statistically significant.
Analyses were performed using the R open-source statistical
software and the SPSS statistical package (version 23 for
Windows. SPSS, Inc. Chicago, Ill).
RESULTS
Patients’ General Characteristics
During the 79 months study period, there have been 3,130
admissions in the FDID of Cotugno Hospital. We retrospectively
included in the final analysis 162 patients with invasive infections
due to S. pneumoniae (male: 48.8%; mean age: 45 years, SD 26;
range: 0–89 years), and 108 patients with invasive infections due
toN. meningitidis (male: 55.6%; mean age: 22 years, SD 22, range:
0–90 years), for a total of 270 cases. Only 3 patients out of 273
cases initially retrieved were excluded, 2 because missing data
about D-dimer levels and 1 for incomplete data about several
clinical characteristics.
Median age was significantly higher in S. pneumoniae than in
N. meningitidis patients (53.5 years, IQR 21–67, vs. 15 years, IQR
3–39, p < 0.001).
Regarding 162 invasive infections due to S. pneumoniae, 132
patients had meningitis (86/132, 65.2%, with concomitant BSI),
and 30 had isolated BSI. Regarding 108 invasive infections due
toN. meningitidis, 90 patients had meningitis (66/90, 73.3%, with
concomitant BSI), and 18 had isolated BSI.
Table 1 shows the results of the analysis of variables for
different etiologies.
All patients (100%) received an adequate empiric
antibiotic treatment before blood and CSF culture results
and then an adequate targeted therapy; 96.7% were treated
with corticosteroids.
The median in-hospital length of stay of overall population
was 17 days (range 0–129 days).
TABLE 1 | Analysis of variables for different etiologies.
S. pneumoniae (n = 162) N. meningitidis (n = 108) p-value
Males, n (%) 79 (48.8%) 60 (55.6%) 0.274
Age (years), median (IQR) 53.5 (21.0–67.0) 15.0 (3.0–39.0) <0.001
SOFA, median (IQR) 3.0 (2.2–6.0) 3.0 (2.0–5.0) 0.465
PLT (×109/mm3 ), median (IQR) 195.5 (145.0–260.0) 167.0 (129.0–232.0) 0.019
Purpura, n (%) 14 (8.6%) 62 (57.4%) <0.001
Splenectomy, n (%) 11 (6.8%) 1 (0.9%) 0.031
BSI isolated, n (%) 30 (18.5%) 18 (16.7%) 0.776
Meningitis isolated, n (%) 46 (28.6%) 24 (22.2%) 0.245
Meningitis + BSI, n (%) 86 (53.1%) 66 (61.1%) 0.122
D-dimer classes (ng/mL) <500 35 (21.6%) 18 (16.7%) 0.002
500–3,000 101 (62.3%) 52 (48.1%)
3,000–7,000 15 (9.3%) 15 (13.9%)
>7,000 11 (6.8%) 23 (21.3%)
D-Dimer >3,000 ng/mL, n (%) 136 (84.0%) 70 (64.8%) <0.001
D-Dimer >7,000 ng/mL, n (%) 11 (6.8%) 23 (21.3%) <0.001
Fibrinogen (mg/dL), median (IQR) 619.5 (469.0–777.0) 574.5 (427.0–720.0) 0.114
D-dimer (ng/mL), median (IQR) 1055.0 (585.0–2239.0) 1314.0 (706.0–4223.0) 0.009
ISTH score positive, n (%) 4 (2.7%) 20 (20.6%) <0.001
mISTH score positive, n (%) 13 (8.0%) 34 (32.1%) <0.001
SIC score positive, n (%) 61 (37.9%) 63 (58.9%) 0.001
ISTH score, median (IQR) 1.0 (1.0–2.0) 2.0 (1.0–4.0) <0.001
mISTH score, median (IQR) 1.0 (1.0–2.0) 2.0 (1.0–4.0) <0.001
SIC score, median (IQR) 3.0 (2.0–4.0) 4.0 (3.0–4.0) 0.003
In-hospital mortality, n (%) 31 (19.1%) 9 (8.3%) 0.014
Composite of mortality or complications, n (%) 75 (46.3%) 20 (18.5%) <0.001
Septic shock, n (%) 48 (29.6%) 40 (37.0%) 0.229
MODS, n (%) 57 (35.2%) 28 (25.9%) 0.101
ICU admission, n (%) 78 (48.1%) 65 (60.2%) 0.052
In all patients (pts), the ISTH overt-DIC score and the SIC score were calculated according to definitions (13–15) within the first 24 h after admission. The cut-off of ISTH overt-DIC
score is 5 (13). The cut-off of modified ISTH (mISTH) overt-DIC score (without fibrinogen) is 4 (17). The cut-off of SIC score is 4 (15). Bold text indicates statistically significant difference
(p < 0.05).
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TABLE 2 | Univariable and multivariable logistic regression analysis (Bayesian model averaging).
Univariable logistic regression Bayesian model averaging
OR (95% CI) p-value OR (95% CI) p (b 6= 0)
N. meningitidis-S. pneumoniae 0.250 (0.133–0.452) <0.001 0.117 (0.111–0.124) 1.000
Fibrinogen 0.999 (0.998–1.000) 0.483 – –
D-dimer (×500 ng/mL) 1.025 (1.007–1.047) 0.010 1.004 (1.003–1.006) 0.157
Male sex 0.533 (0.312–0.904) 0.020 0.886 (0.855–0.918) 0.206
Age 1.022 (1.011–1.033) <0.001 1.001 (1.000–1.002) 0.071
ICU admission 2.587 (1.499–4.549) <0.001 1.241 (1.175–1.310) 0.254
SOFA 1.221 (1.118–1.342) <0.001 1.185 (1.174–1.956) 0.926
Platelet count 1.001 (0.998–1.003) 0.686 – –
Splenectomy 0.968 (0.247–3.302) 0.959 – –
Septic shock 2.808 (1.621–4.907) <0.001 1.583 (1.486–1.687) 0.533
MODS 3.519 (2.012–6.234) <0.001 1.003 (0.992–1.015) 0.030
Purpura 0.705 (0.385–1.261) 0.245 – –
BSI isolated 0.628 (0.293–1.274) 0.211 – –
Meningitis isolated 0.862 (0.458–1.587) 0.638 – –
Meningitis + BSI 1.581 (0.927–2.725) 0.095 1.003 (0.996–1.010) 0.025
ISTH score 1.034 (0.882–1.208) 0.678 – –
SIC score 1.224 (0.971–1.559) 0.092 1.010 (1.003–1.017) 0.054
Interaction (×500 D-dimer) 1.014 (0.996–1.027) 0.140 1.041 (1.038–1.045) 0.849
The variables that are selected in the final multivariable model are N. meningitidis–S. pneumoniae, SOFA and D-dimer-N. meningitidis. At multivariable analysis, the D-dimer has no effect
on the whole population, but only on the subgroup of patients with N. meningitidis. As 500 ng/mL of D-dimer increase, the probability of a negative outcome increases on average by 4%.
TABLE 3 | Streptococcus pneumoniae.
Survivors (n = 131) Deaths (n = 31) p-value
Males, n (%) 64 (48.9%) 15 (48.4%) 0.963
Septic shock, n (%) 22 (16.8%) 26 (83.9%) <0.001
MODS, n (%) 31 (23.7%) 26 (83.9%) <0.001
Purpura, n (%) 7 (5.3%) 7 (24.1%) 0.004
BSI isolated, n (%) 29 (22.1%) 1 (3.3%) 0.020
Meningitis isolated, n (%) 43 (32.8%) 3 (10.0%) 0.013
Meningitis + BSI, n (%) 59 (45.0%) 27 (87.1%) <0.001
Fibrinogen (mg/dL), median (IQR) 621.0 (458.0–777.0) 590.0 (500.0–780.0) 0.766
D-dimer (ng/mL), median (IQR) 974.0 (513.0–1652.0) 1578.0 (944.0–2872.0) 0.009
Age, years, median (IQR) 47.0 (13.0–65.0) 63.0 (49.0–48.0) 0.002
SOFA, median (IQR) 3.0 (2.0–5.0) 7 (4.0–8.0) <0.001
PLT (×109), median (IQR) 200.0 (153.0–264.0) 169.0 (128.0–242.0) 0.085
ISTH score, median (IQR) 1.0 (1.0–2.0) 1.0 (1.0–3.0) 0.678
mISTH score, median [IQR] 1.0 [1.0 – 2.0] 1.0 [1.0 – 3.0] 0.550
SIC score, median (IQR) 3.0 (2.0–4.0) 3.5 (3.0–5.0) 0.021
Association between variables and in-hospital mortality. Bold text indicates statistically significant difference (p < 0.05).
143/270 (53%) patients needed admission in intensive care
unit (ICU) during the hospital stay.
SOFA Score
48/270 patients (17.8%) had SOFA score<2 (absence of criteria
for sepsis diagnosis): none of these died. No statistically
significant difference (p = 0.465) was found for median SOFA
scores between S. pneumoniae (3, IQR 2–6) and N. meningitidis
(3, IQR 2–5) groups (Table 1).
For S. pneumoniae infections, the median SOFA was 7 (IQR
4–8) in non-survivors vs. 3 (IQR 2–5) in survivors (p < 0.001;
Table 3), while for N. meningitidis infections it was 6.5 (IQR
4–9.5) vs. 3 (IQR 2–5) (p= 0.010; Table 4).
At the univariable and multivariable logistic regression
analysis (Table 2), the SOFA score was significantly associated
with in-hospital mortality in the overall population.
An acute change in total SOFA score ≥2 points, defining
the sepsis-related organ dysfunction according to the sepsis-3
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TABLE 4 | Neisseria meningitidis.
Survivors (n = 99) Deaths (n = 9) p-value
Males, n (%) 55 (55.6%) 5 (55.6%) 1.000
Septic shock, n (%) 32 (32.3%) 8 (88.9%) 0.001
MODS, n (%) 21 (21.2%) 7 (77.8%) 0.001
Purpura, n (%) 57 (58.2%) 5 (62.5%) 1.000
BSI isolated, n (%) 16 (16.2%) 2 (22.2%) 0.643
Meningitis isolated, n (%) 23 (23.2%) 1 (11.1%) 0.680
Meningitis + BSI, n (%) 60 (60.6%) 6 (66.7%) 1.000
Fibrinogen (mg/dL), median (IQR) 576.0 (437.0–720.0) 233.0 (96.0–720.0) 0.233
D-dimer (ng/mL), median (IQR) 1140.0 (688.0–3543.0) 8051.0 (3859.0–40601.0) 0.001
Age, years, median (IQR) 15.0 (3.5–34.0) 5.0 (1.5–48.0) 0.739
SOFA, median (IQR) 3.0 (2.0–5.0) 6.5 (4.0–9.5) 0.010
PLT (×109), median (IQR) 170.0 (129.0–232.0) 155.0 (131.0–175.0) 0.405
ISTH score, median (IQR) 2.0 (1.0–4.0) 5.0 (3.0–5.0) 0.035
mISTH score, median (IQR) 2.0 (1.0–4.0) 5.0 (3.0–5.0) 0.041
SIC score, median (IQR) 4.0 (3.0–4.0) 4. 0 (3.5–5.0) 0.090
Association between variables and in-hospital mortality. Bold text indicates statistically significant difference (p < 0.05).
criteria, was present in 136 (84.0%) S. pneumoniae patients and
in 86 (79.6%) N. meningitidis patients: the difference was not
statistically significant.
Invasive Infection Type
At the univariable and multivariable logistic regression analysis
(Bayesian model averaging), the type of invasive infection
(meningitis with BSI, meningitis without BSI, isolated BSI) was
not found to be a variable significantly associated with in-hospital
mortality (Table 2).
Previous Splenectomy and Purpura at
Admission
More patients with invasive infections due to S. pneumoniae than
N. meningitidis previously underwent splenectomy (6.8 vs. 0.9%,
p = 0.031), but at the univariable logistic regression analysis, a
history of splenectomywas not found to be a variable significantly
associated with in-hospital mortality (Table 2).
8.6% of S. pneumoniae patients had purpura at admission: 50%
of these previously underwent splenectomy; out of the total of 11
splenectomized patients, 7 (63.6%) presented with purpura.
57.4% of N. meningitidis patients had purpura at admission:
only 1 patient (1.6%) previously underwent splenectomy: in this
patient D-dimer levels were <500 ng/mL.
Therefore, significantly more patients with invasive infections
due to N. meningitidis compared to S. pneumoniae early
presented purpura (57.4 vs. 8.6%, p < 0.001). Purpura
was significantly more frequent in N. meningitidis than
in S. pneumoniae patients regardless of D-dimer classes,
and, independently by etiology, purpura prevalence was not
significantly different between the different D-dimer classes. At
the univariable logistic regression analysis (Table 2), the presence
of purpura was not a variable significantly associated with in-
hospital mortality.
D-Dimer
Data analysis for continuous variables (Table 1) showed that D-
dimer levels were significantly higher in N. meningitidis than S.
pneumoniae patients: median 1,314 ng/mL (IQR 706–4,223) vs.
1,055 ng/mL (IQR 585–2,239), p= 0.009.
35/162 (21.6%) S. pneumoniae patients and 18/108 (16.7%) N.
meningitidis patients had D-dimer <500 mg/dL.
101/162 (62.3%) of S. pneumoniae patients and 52/108 (48.1%)
of N. meningitidis patients had D-dimer 500–3,000 ng/mL.
15/162 (9.3%) of S. pneumoniae patients and 15/108 (13.9%)
N. meningitidis patients had D-dimer 3,000–7,000 ng/mL.
11/162 (6.8%) of S. pneumoniae patients and 23/108 (21.3%)
N. meningitidis patients had D-dimer >7,000 ng/mL.
Most patients thus had D-dimer levels belonging to the class
500–3,000 ng/mL.
Fibrinogen
Data analysis for continuous variables (Table 1) showed that
fibrinogen levels were not significantly different between S.
pneumoniae and N. meningitidis patients: median 619.5 mg/dL
(IQR 469.0–777.0) vs. 574.5 mg/dL (IQR 427.0–720.0), p= 0.114.
At the logistic univariable regression analysis
(Table 2) fibrinogen was not significantly associated with
in-hospital mortality.
Only 4/249 (1.6%) patients, all presenting N. meningitidis
BSI (1 isolated and 3 with meningitis), had fibrinogen levels
<100 mg/dL; 3 of these 4 patients had shock and MODS, and
2 of these 3 died. Also elevating the cut-off to 200 mg/dL, we
retrieved only 6 N. meningitidis and 3 S. pneumoniae patients
with reduced levels: 7 of these 9 patients had shock and/or
MODS and 4 out of these 7 patients ultimately died (mortality
rate: 44.4%).
In definitive, only 9/249 patients (3.6%) had fibrinogen levels
reduced under the normal value of 200 mg/dL.
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MODS
MODS occurred in 35.2% of S. pneumoniae patients and in
25.9% of N. meningitidis patients, without statistically significant
difference (p= 0.101;Tables 1, 5). No significant differences were
observed within each single D-dimer class.
Streptococcus pneumoniae patients with D-dimer levels <500
and 500–3,000 ng/mL showed similar rates of early presentation
of MODS (31.4 and 29.7%, respectively), and the percentages
were about the same also comparing the classes 3,000–
7,000 ng/mL and over 7,000 ng/mL (60 and 63.6%, respectively,
Table 5); for D-dimer levels >3,000 ng/mL a statistically
significant (p= 0.001) two-fold increase of occurrence of MODS
was observed.
In N. meningitidis patients, the percentage of MODS
progressively and significantly increased as D-dimer increased
(Table 5), from 11.1% for values <500 ng/mL to 52.2% for values
>7,000 ng/mL (p= 0.007); when D-dimer exceeded 7,000 ng/mL
the rate of MODS significantly increased compared to lower
values (p= 0.001).
Of the S. pneumoniae patients who died, 83.9% had
MODS, while this percentage was only 23.7% among
patients who survived: this difference was significant (p
< 0.001). For N. meningitidis patients the corresponding
percentages were 77.8 and 21.2%, and the difference was
still significant (p = 0.001; Tables 3, 4). At the univariable
logistic regression analysis, MODS was found to be a
variable significantly (p < 0.001) associated with in-hospital
mortality (Table 2).
Septic Shock
The occurrence of septic shock was not significantly different
between S. pneumoniae and N. meningitidis patients (29.6 vs.
37%, p = 0.229) (Table 1), and was very high regardless of
D-dimer class (Table 5).
Of the S. pneumoniae patients who died, 83.9% had septic
shock, while this percentage was only 16.8% among patients
who survived: this difference was significant (p < 0.001). For N.
meningitidis patients the corresponding percentages were 88.9
and 32.3%, and the difference was still significant (p = 0.001;
Tables 3, 4). At the univariable logistic regression analysis, septic
shock was found to be significantly (p < 0.001) associated with
in-hospital mortality (Table 2).
About 33% of N. meningitidis patients with D-dimer
levels <7,000 ng/mL and 52.2% of those with D-dimer
levels >7,000 ng/mL early presented septic shock, without
significant differences between every D-dimer classes (p
= 0.411); also comparing only D-dimer classes under and
over 7,000 ng/mL the difference was still not significant
(p= 0.090).
In-hospital Mortality (Primary Outcome)
In-hospital mortality was 14.8% (40/270 patients) for the overall
population, and was significantly higher in S. pneumoniae
than in N. meningitidis patients: 19.1 vs. 8.3%, respectively
(p= 0.014; Table 1).
At the univariable logistic regression analysis, the type of
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isolated BSI) was not significantly associated with in-hospital
mortality, and this data is conformed to the Bayesian model
averaging (Table 2).
At the univariable logistic regression analysis (Table 2), ICU
admission was found to be significantly associated with in-
hospital mortality.
The median survival time in patients who died was 1 day
(range 0–18 days) in theN.meningitidis group and 21 days (range
0–129 days) in the S. pneumoniae group.
At the analysis of the association between continuous variables
and outcomes (Tables 3, 4), median D-dimer levels were
significantly higher in non-survivors than in survivors, both for S.
pneumoniae (1,578 vs. 974 ng/mL, p= 0.009) andN. meningitidis
(8,051 vs. 1,140 ng/mL, p < 0.001).
In-hospital mortality gradually increased as D-dimer
values increased, but the overall trend was significant for N.
meningitidis group (p = 0.010) and non-significant for S.
pneumoniae (p= 0.420).
At the univariable logistic regression analysis (Table 2), the
following variables were significantly associated with in-hospital
mortality: pneumococcal etiology (p < 0.001), female sex (p =
0.020), age (p < 0.001), ICU admission (p < 0.001), SOFA score
(p < 0.001), septic shock (p < 0.001), MODS (p < 0.001), and
D-dimer levels (p= 0.010).
For odds ratio (OR) of D-dimer, we considered an increase of
500 ng/mL. At multivariable analysis, the D-dimer did not show
an effect on the whole population, but only on the group of N.
meningitidis patients: in this group, as 500 ng/mL of D-dimer
increased, the probability of unfavorable outcome increased on
average by 4%.
For N. meningitidis the in-hospital mortality was 0% for D-
dimer levels <500 ng/mL, very low (3.5%) for D-dimer levels
<7,000 ng/mL, and increased to 26.1% for D-dimer exceeding
the cut-off of 7,000 ng/mL (Table 5). Differences between classes
were significant (p= 0.010), as well as between values under and
above 7,000 ng/mL (p= 0.003).
Kaplan-Meier analysis of in-hospital mortality showed for N.
meningitidis subjects a statistically significant difference for D-
dimer levels >7,000 ng/mL compared to values <500 ng/mL (p
= 0.021) and to values 500–3,000 ng/mL (p= 0.002; Figure 1).
For S. pneumoniae the trend of the in-hospital mortality
increasing as D-dimer increased was not statistically significant
(p = 0.420), and the mortality was very high (11.4%) also in case
of normal D-dimer levels <500 ng/mL (Table 5).
The mortality related to S. pneumoniae infections was
always higher than N. meningitidis (Table 5), and was
statistically significant in the D-dimer class of 500–3,000 ng/mL,
representative of most population (19.8 vs. 3.8%, p = 0.008);
for classes <500 and 3,000–7,000 ng/mL the overall trend was
confirmed but without reaching the statistical significance (11.4
vs. 0%, p= 0.287, and 26.7 vs. 6.7%, p= 0.330), and for D-dimer
values over 7,000 ng/mL the mortality was not different (27.3 vs.
26.1%, p= 1.000).
Among patients with purpura the in-hospital mortality was
50% in case of S. pneumoniae infections and 8.1% for N.
meningitidis. Purpura did not correlate with in-hospital mortality
in N. meningitidis patients (p = 1.000), but was significantly
more frequent in non-survivors from invasive infections due
to S. pneumoniae (24.1 vs. 5.3%, p = 0.004) (Tables 3, 4).
At the univariable logistic regression analysis (Table 2), the
FIGURE 1 | Kaplan-Meier analysis of in-hospital mortality in patients with infections due to Streptococcus pneumoniae (A) and Neisseria meningitidis (B).
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presence of purpura was not significantly associated with in-
hospital mortality.
Finally, we investigated the ability of D-dimer in predicting
in-hospital mortality in the subgroup of patients early presenting
with purpura. The rate of in-hospital mortality was 0%
(0/45) in N. meningitidis patients with purpura and D-
dimer levels <7,000 ng/mL and 29.4% (5/17) when D-dimer
levels exceeded 7,000 ng/mL: this difference was statistically
significant (p= 0.001).
The rate of in-hospital mortality was 0% (0/3) also in
S. pneumoniae patients with purpura and D-dimer levels
>3,000 ng/mL vs. 63.6% (7/11) among patients with D-
dimer levels <3,000 ng/mL, but this difference was not
significant (p= 0.192).
Composite Outcome of In-hospital
Mortality or Complications
The composite outcome of in-hospital mortality or complications
was 35.2% (95/270 patients) for the overall population, occurring
more frequently in patients with invasive infections due to S.
pneumoniae than in those with N. meningitidis (46.3 vs. 18.5%,
p < 0.001) (Table 1).
For D-dimer levels <500 and 500–3,000 ng/mL, this outcome
occurred significantly more frequently in S. pneumoniae patients
than those with infections due to N. meningitidis (34.3 vs. 0%, p
= 0.004, and 49.5 vs. 17.3%, p < 0.001, respectively), while the
trend was still evident but not statistically significant for classes
3,000–7,000 and >7,000 ng/mL (40 vs. 20%, p = 0.427, and 63.6
vs. 34.8%, p= 0.151, respectively) (Table 5).
Among N. meningitidis patients there were no complications
when D-dimer values were<500mg/dL, but the risk significantly
increased for higher values (17.3% for 500–3,000 ng/mL, 20% for
3,000–7,000 ng/mL and 34.8% for >7,000 ng/mL, p = 0.029). In
S. pneumoniae patients, this composite outcome occurred instead
very frequently independently by D-dimer classes (ranging from
34.3 to 63.6%, p= 0.246) (Table 5).
In case of purpura, among S. pneumoniae patients this
composite outcome was met in 10/14 patients (71.4%), in N.
meningitidis patients in 19.4% (12/62).
Finally, we conducted a sub-analysis about the predictive
ability of D-dimer in the subgroup of patients with purpura.
This composite outcome occurred in 11.1% (5/45) of N.
meningitidis patients with D-dimer levels <7,000 ng/mL and
in 41.2% (7/17) in those with D-dimer levels >7,000 ng/mL:
the difference was statistically significant (p = 0.013). In S.
pneumoniae patients with D-dimer levels >3,000 ng/mL this
outcome occurred in 33.3% (1/3), compared to 81.8% (9/11) in
patients with D-dimer levels <3,000 ng/mL: this difference was
not significant (p= 0.176).
DISCUSSION
Coagulopathy is crucially involved in the pathogenesis of sepsis-
related dysregulated host response to infections: the differences
between Gram-negative and Gram-positive bacteria, due to
profound differences in their cell wall composition and the
specificity of bacterial exotoxins production (18, 19), and the
consequent interaction with the innate immune system, affect
both the induction of immunothrombosis and the evolution
of coagulopathy. The Pathogen-Associated Molecular Patterns
(PAMPs) are indeed specific for differentmicroorganisms and are
basically involved in determining the coagulopathy-related organ
damage: the lipopolysaccharide (LPS), one of the most important
cell wall component of Gram-negative bacteria, is precociously
recognized by innate immune system via toll-like receptor
(TLR) 4, while the lipoteichoic acid, a cell wall component
of Gram-positive bacteria, is mainly recognized by TLR2 (12);
as differences in activation of these receptors can result in
different production of inflammatory cytokines by the host, we
should also expect a peculiar pattern of coagulopathy. During
BSI due to N. meningitidis, besides the presence of elevated
levels of circulating LPS, monocytes have been shown to express
high level of functional TF, correlating with disease severity,
and TF-bearing circulant MPs able to initiate the extrinsic
coagulation pathway have been isolated in large amount (20).
Moreover, human monocytes exposed to LPS produce both TF
and plasminogen activator inhibitor (PAI)-2, both favoring fibrin
deposition, but evidence showed that cellular production of these
molecules may be uncoupled, since exposition to alloantigens
leads to high levels of TF with no concomitant increase in PAI-
2 activity (21). Hence, the procoagulant and the fibrinolytic
pathways can be differently involved. Therefore, a great
heterogeneity in the hemostatic aspects of the immune response
and distinct patterns of coagulopathy in response to different
microorganisms are expected, causing distinctive imbalance of
the main determinants, namely the activation of coagulation,
the down-regulation of physiological anticoagulants, and the
inhibition of fibrinolysis (5).
Coagulation biomarkers could be useful to characterize the
extent and/or type of coagulopathy occurring during sepsis
and/or severe invasive infections due to different pathogens.
In effect, thrombin-antithrombin complex, PAI-1 and D-
dimer have been already proposed as potential biomarkers
for the identification of the clinical phenotypes of sepsis,
being significantly associated with the δ phenotype, which is
characterized by a distinctive pattern of organ dysfunction
and higher mortality (2); thereafter, such biomarkers might
be useful in identifying those patients most likely to benefit
from anti-inflammatory, anti-coagulant or immunomodulatory
strategies (17).
Several coagulation factors could be measured, but screening
all patients with an extensive panel of biomarkers would
be expensive and dispersive; moreover, the complex balance
between the pro- and anti-thrombotic and the pro- and anti-
fibrinolytic drive occurring in response to different pathogens
could be more simply synthetized by a molecule produced at the
end of these interconnected cascades.
D-dimer satisfies several ideal criteria that a biomarker should
have (3), such as the plausibility (the credible mechanism
connecting the marker with the pathogenesis of the disease) and
the coherence (the consistency of the association between the
marker and the natural history of the disease). A biomarker
should ideally be consistent, that is the association should
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persist in different individuals, in different places, in different
circumstances, and at different times (3). Semeraro et al. (6,
7) reported a higher mortality in sepsis patients with low D-
dimer, while other studies conducted on sepsis (10), but also
on IE (8), BSI (9), and COVID-19 (11) conversely reported a
worse prognosis for patients with high D-dimer values: in our
opinion, these opposite findings should be interpreted not as
an example of inconsistency of D-dimer as biomarker, but as
the expression of its specificity to be differently associated with
specific conditions and specific pathogens. This aspect has not
been adequately taken into account in previous clinical studies:
Schwameis et al. (9) enrolled in the same case series BSI due
to S. aureus, E.coli, and P. aeruginosa, and Semeraro et al. (6)
conducted their investigation using the data of the ALBIOS study
(22), in which over 40% of patients did not have amicrobiological
diagnosis, and for the remaining no bacterial species was
specifically reported or specifically studied for the interaction
between coagulative biomarkers and clinical outcomes.
In our study we have clearly distinguished invasive infections
due to S. pneumoniae from those due to N. meningitidis,
and this was a strength of our study. Another strength
is to have specifically investigated the association with
relevant clinical outcomes depending by D-dimer levels
early assessed at admission to the hospital. Median D-dimer
levels were significantly higher in N. meningitidis than in S.
pneumoniae patients.
Our results do not confirm the findings of Semeraro et al. (6, 7)
about a higher mortality for low D-dimer levels, and agree with
those of Turak et al. (8) and Schwameis et al. (9): we found for
N. meningitidis an in-hospital mortality varying from 0% for D-
dimer levels <500 ng/mL to 26.1% for values exceeding the cut-
off of 7,000 ng/mL, progressively increasing on average by 4% as
500 ng/mL of D-dimer increase. For S. pneumoniae the mortality
was always very high, regardless of D-dimer levels, being already
11.4% for normal values. Similarly, for N. meningitidis the
composite outcome of mortality or complications increased as
D-dimer increased. The strength of the association with the
outcome (3), which is a central feature for a good biomarker, was
thus more robust for invasive infections due to N. meningitidis.
The only subgroup of our cohort in which lower D-dimer levels
seemed associate with worse outcomes was that of S. pneumoniae
patients with purpura, showing an in-hospital mortality of 63.6%
when D-dimer levels were <3,000 ng/mL vs. 0% when D-dimer
was >3,000 ng/mL: anyway, this difference was not significant. It
is possible that the number of the sample size does not allow to
highlight significant differences, so further studies are warranted
to verify this finding.
It is noteworthy to observe that there have been no
complications among N. meningitidis patients with normal
D-dimer values <500 ng/mL, while for S. pneumoniae the
composite of in-hospital mortality or complications occurred
already in about one third of patients with normal values:
this percentage was reached in N. meningitidis patients only
for values >7,000 ng/mL. Therefore, D-dimer reflects only in
part the complexity of the dysregulated host response finally
leading to organ dysfunction and death. Since coagulopathy
is a central element in the dysregulated host response leading
to organ dysfunction, we assessed the association between D-
dimer and MODS. In N. meningitidis infections the rate of
MODS progressively and significantly increased as D-dimer
increased; in S. pneumoniae invasive infections, a D-dimer cut-
off of 3,000 ng/mL seems identify those patients with a significant
two-fold increase of occurrence of MODS.
In our study, the mortality related to S. pneumoniae infections
was higher than N. meningitidis in all D-dimer classes. A
higher mortality in purpura fulminans due to S. pneumoniae
compared to other pathogens (mainly N. meningitidis) has been
recently reported by Contou et al. (23) in a multicenter French
retrospective study including 306 cases admitted in ICUs from
2000 to 2016; the reason of a significantly higher mortality in that
cohort compared to our data (41.2 vs. 14.8%) may be due to the
different condition taken in account, specifically the enrollment
only of the cases with evolution toward purpura fulminans. In
our cohort only 8.6% of S. pneumoniae patients and 57.4% of N.
meningitidis patients presented with purpura; like Contou et al.
(23), also in our cohort the mortality was higher in this subgroup,
50 and 8.1% for S. pneumoniae and N. meningitidis, respectively,
even if at the univariable logistic regression analysis purpura was
not a variable significantly associated with in-hospital mortality.
The concepts of sepsis [according to the sepsis-3 definition
(1)], coagulopathy (concerning pathophysiologic aspects and
possibly reflected by D-dimer), overt-DIC [definable through
clinical scores (13, 14)], even if interconnected, should be
kept distinct, concerning different points of view of the same
phenomenon, and it should be noted that these conditions
often do not coexist, as evidenced by the discrepant percentages
observed among our patients concerning presence of sepsis,
elevated D-dimer levels, coagulopathy defined by SIC score (15),
and overt-DIC defined by ISTH score (82.2, 80.4, 45.9, and
8.9%, respectively).
Finally, several studies have evaluated the role of
prognostic biomarkers in case of bacterial meningitis: matrix
metalloproteinases-8 assessed on CSF has been presented
as an attractive prognostic biomarker in children (24), and
longitudinal analysis of CSF lactate resulted to be an important
predictor of prognosis (25). However, the advantage of
measuring a biomarker directly from venous blood, in an
easy and inexpensive way, with results rapidly available and
everywhere, is evident.
D-dimer levels under a cut-off of 7,000 ng/mL, assessed within
24 h after admission, have shown to accurately predict a very
low in-hospital mortality rate (3.5%) in case of infection due
to N. meningitidis, and normal values <500 ng/mL excluded
any further complications. For S. pneumoniae, D-dimer did not
show the same ability to predict an increased risk of death,
supporting the conclusion that D-dimer is a biomarker with a
certain specificity in reflecting the dysregulated host coagulative
response depending by specific pathogens.
Study Limitations
The main limitation of this study is represented by the
retrospective design, with bias and confounding being
known errors potentially affecting the validity of these
studies. Nevertheless, we conducted data analysis performing
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logistic regression analysis with Bayesian model averaging, to
minimize confounders.
Another limitation is represented by a relatively small sample
size that possibly did not allow to highlight significant differences
in some cases, so further studies are warranted. Anyway,
to the best of our knowledge, this cohort of patients with
meningitis and/or BSI investigated for coagulation biomarkers
early assessed within 24 h after admission represents one of the
largest published so far.
Finally, our study has been conducted in a single center
institution, thus composition of patient population, local
resources, medical protocols, and staffing characteristics may
limit the generalizability of results.
CONCLUSIONS
D-dimer is rapid to be obtained, at low cost and available
everywhere, and seems to be an interesting biomarker able to
reflect the concept of the dysregulated host response in case of
invasive infections due to N. meningitidis and S. pneumoniae.
Assessment of D-dimer within 24 h after admission can help
stratify the risk of in-hospital mortality and complications in
patients with meningitis and/or BSI due to N. meningitidis: D-
dimer values <500 ng/mL exclude any further complications,
and a D-dimer cut-off of 7,000 ng/mL seems able to predict a
significantly increased risk of in-hospital mortality from much
<10% to over 25%. For S. pneumoniae invasive infections the
mortality risk resulted always high, over 10%, irrespective by
D-dimer values.
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